Skip to main content

MorphoSys Inks Antibody Development, Distribution Agreement with Sigma-Aldrich

This article has been updated to clarify the fact that Sigma-Aldrich is distributing antibodies derived from the HuCAL Gold library.
NEW YORK (GenomeWeb News) – MorphoSys said today it has agreed to a research antibody design and distribution agreement with Sigma-Aldrich.
Under the agreement, MorphoSys’s Serotec business unit will develop and qualify unique recombinant research antibodies from its HuCAL Gold library against targets identified by Sigma-Aldrich, which will distribute the antibodies, MorphoSys said.
Sigma-Aldrich will offer the HuCAL-based antibodies through its Antibody Explorer and Your Favorite Gene search platforms.
The HuCAL-based antibody technology “will allow researchers access to antibody content not available through standard antibody generation technologies,” said David Smoller, president of Sigma-Aldrich’s Research Biotech business unit.
Smoller also said that in conjunction with Sigma-Aldrich’s standard content generation capabilities, the research antibody technology “is expected to allow the community to reach its goal of a binder for every gene and one day even protein in the human body.”
Financial terms of the agreement were not released.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.